PharmaPrime Revenue and Competitors

Roma,

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • PharmaPrime's estimated annual revenue is currently $5.5M per year.(i)
  • PharmaPrime's estimated revenue per employee is $189,000

Employee Data

  • PharmaPrime has 29 Employees.(i)
  • PharmaPrime grew their employee count by 61% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$354.2M9376%N/AN/A
#2
$4.5M24-14%N/AN/A
#3
$25.9M96-14%N/AN/A
#4
$18M74-16%N/AN/A
#5
$10.8M509%N/AN/A
#6
$32.9M1228%N/AN/A
#7
$187.3M5559%N/AN/A
#8
$417.7M110522%N/AN/A
#9
$25.9M9628%N/AN/A
#10
$108.7M3228%N/AN/A
Add Company

What Is PharmaPrime?

PharmaPrime is an italian startup born to facilitate the daily lives of those who live and work in the metropolis. We actually cover Rome, Milan, Bologna and Genoa. This is an online platform that allows access to pharmaceutical, cosmetic and parafarmaceutic products, guaranteeing delivery within 40 minutes and considerable customer savings. Thanks to an ad hoc algorithm, in fact, you can find the pharmacy that sells the desired products at the cheapest price. The connection of the PharmaPrime web platform with pharmacy systems offers the customer the availability of real-time products, over 1.8 million different products compared to the 5,000 on average in a pharmacy and provides the latter with a direct channel for the acquisition of new customers without any kind of expense in logistics, marketing or technology infrastructures.

keywords:N/A

N/A

Total Funding

29

Number of Employees

$5.5M

Revenue (est)

61%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PharmaPrime News

2022-03-22 - PharmaPrime al fianco delle persone affette da narcolessia

In occasione della Giornata Mondiale delle Malattie Rare, PharmaPrime accende i riflettori sui bisogni della Comunità di persone che...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.5M32N/AN/A
#2
$3.8M33N/AN/A
#3
N/A3540%N/A
#4
$6.1M37-26%N/A
#5
$7.1M386%N/A